Back to Journals » Drug Design, Development and Therapy » Volume 7

Alemtuzumab: evidence for its potential in relapsing–remitting multiple sclerosis

Total article views   HTML views PDF downloads Totals
16,781 Dovepress* 12,597+ 2,533 15,130
PubMed Central* 4,184 1,424 5,608
Totals 16,781 3,957 20,738
*Since 6 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 1 0 4

View citations on PubMed Central and Google Scholar